Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Oncternal Therapeutics, Inc.Listing unverified | BuyD (derivative) | $1.2M | ClusterFirst in 12mo | SEC | |
Oncternal Therapeutics, Inc.Listing unverified | Buy | $2.5M | conv 66ClusterFirst in 12mo | SEC | |
Oncternal Therapeutics, Inc.Listing unverified | Award | n/a (No price was disclosed in the filing) | SEC |